Use of corticosteroids after hepatoportoenterostomy for bile drainage in infants with biliary atresia the start randomized clinical trial

JAMA

Volumn 311, Issue 17, 2014, Pages 1750-1759

  Bezerra, Jorge A ^a   Spino, Cathie ^b   Magee, John C ^b   Shneider, Benjamin L ^c   Rosenthal, Philip ^d   Wang, Kasper S ^e   Erlichman, Jessi ^f   Haber, Barbara ^f,q   Hertel, Paula M ^g   Karpen, Saul J ^h   Kerkar, Nanda ^e,i   Loomes, Kathleen M ^f   Molleston, Jean P ^j   Murray, Karen F ^k   Romero, Rene ^h   Schwarz, Kathleen B ^l   Shepherd, Ross ^g   Suchy, Frederick J ^m   Turmelle, Yumirle P ⁿ   Whitington, Peter F ^o   Moore, Jeffrey ^b   Sherker, Averell H ^p   Robuck, Patricia R ^p   Sokol, Ronald J ^m   more..

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^g TEXAS CHILDREN S HOSPITAL   (United States)

^h EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^j INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k SEATTLE CHILDREN S HOSPITAL   (United States)

^l JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^m UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

ⁿ WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^o CHILDREN'S MEMORIAL HOSPITAL   (United States)

^p NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^q MERCK RESEARCH LABORATORIES   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE; HEMOGLOBIN; METHYLPREDNISOLONE; PLACEBO; PREDNISOLONE;

ARTICLE; ATTRIBUTABLE RISK; BACTEREMIA; BILE DUCT ATRESIA; BILIARY TRACT DRAINAGE; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; DISEASE DURATION; DOUBLE BLIND PROCEDURE; DRUG MEGADOSE; DRUG SAFETY; FEMALE; FEVER; FRACTURE; FUNGEMIA; GASTROINTESTINAL DISEASE; GASTROINTESTINAL HEMORRHAGE; HUMAN; HYPERGLYCEMIA; HYPOKALEMIA; INFANT; INTERNATIONAL NORMALIZED RATIO; LEUKOCYTE COUNT; LIVER; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NUTRITIONAL DEFICIENCY; OUTCOME ASSESSMENT; PORTOENTEROSTOMY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN DISEASE; SURVIVAL; THROMBOCYTE COUNT; TREATMENT DURATION; UNITED STATES; UNSPECIFIED SIDE EFFECT; VIRUS INFECTION;

ADMINISTRATION, ORAL; ADRENAL CORTEX HORMONES; BILIARY ATRESIA; BILIRUBIN; DOUBLE-BLIND METHOD; DRAINAGE; FEMALE; HUMANS; INFANT; INFUSIONS, INTRAVENOUS; MALE; METHYLPREDNISOLONE; PORTOENTEROSTOMY, HEPATIC; PREDNISOLONE; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84899880980     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2014.2623     Document Type: Article

References (27)

1. Sokol RJ, Shepherd RW, Superina R, Bezerra JA, Robuck P, Hoofnagle JH. Screening and outcomes in biliary atresia: summary of a National Institutes of Health workshop. Hepatology. 2007;46(2):566-581.
2. Shneider BL, Brown MB, Haber B, et al Biliary Atresia Research Consortium. A multicenter study of the outcome of biliary atresia in the United States, 1997 to 2000. J Pediatr. 2006;148(4):467-474.
3. Chardot C, Buet C, Serinet MO, et al. Improving outcomes of biliary atresia: French national series 1986-2009. J Hepatol. 2013;58(6):1209-1217.
4. Karrer FM, Lilly JR. Corticosteroid therapy in biliary atresia. J Pediatr Surg. 1985;20(6):693-695.
5. Kasai M, Suzuki H, Ohashi E, Ohi R, Chiba T, Okamoto A. Technique and results of operative management of biliary atresia. World J Surg. 1978;2(5):571-579.
6. Dillon PW, Owings E, Cilley R, Field D, Curnow A, Georgeson K. Immunosuppression as adjuvant therapy for biliary atresia. J Pediatr Surg. 2001;36(1):80-85.
7. Escobar MA, Jay CL, Brooks RM, et al. Effect of corticosteroid therapy on outcomes in biliary atresia after Kasai portoenterostomy. J Pediatr Surg. 2006;41(1):99-103.
8. Kobayashi H, Yamataka A, Koga H, et al. Optimum prednisolone usage in patients with biliary atresia postportoenterostomy. J Pediatr Surg. 2005;40(2):327-330.
9. Meyers RL, Book LS, O'Gorman MA, et al. High-dose steroids, ursodeoxycholic acid, and chronic intravenous antibiotics improve bile flow after Kasai procedure in infants with biliary atresia. J Pediatr Surg. 2003;38(3):406-411.
10. Muraji T, Higashimoto Y. The improved outlook for biliary atresia with corticosteroid therapy. J Pediatr Surg. 1997;32(7):1103-1107.
11. Muraji T, Nio M, Ohhama Y, et al Japanese Biliary Atresia Society. Postoperative corticosteroid therapy for bile drainage in biliary atresia - a nationwide survey. J Pediatr Surg. 2004;39(12):1803-1805.
12. Tatekawa Y, Muraji T, Tsugawa C. Glucocorticoid receptor alpha expression in the intrahepatic biliary epithelium and adjuvant steroid therapy in infants with biliary atresia. J Pediatr Surg. 2005;40(10):1574-1580.
13. Davenport M, Parsons C, Tizzard S, Hadzic N. Steroids in biliary atresia: single surgeon, single centre, prospective study. J Hepatol. 2013;59(5):1054-1058.
14. Davenport M, Stringer MD, Tizzard SA, McClean P, Mieli-Vergani G, Hadzic N. Randomized, double-blind, placebo-controlled trial of corticosteroids after Kasai portoenterostomy for biliary atresia. Hepatology. 2007;46(6):1821-1827.
15. Lao OB, Larison C, Garrison M, Healey PJ, Goldin AB. Steroid use after the Kasai procedure for biliary atresia. Am J Surg. 2010;199(5):680-684.
16. Sarkhy A, Schreiber RA, Milner RA, Barker CC. Does adjuvant steroid therapy post-Kasai portoenterostomy improve outcome of biliary atresia? systematic review and meta-analysis. Can J Gastroenterol. 2011;25(8):440-444.
17. Shneider BL, Magee JC, Bezerra JA, et al Childhood Liver Disease Research Education Network (ChiLDREN). Efficacy of fat-soluble vitamin supplementation in infants with biliary atresia. Pediatrics. 2012;130(3):e607-e614.
18. Agresti A. Categorical Data Analysis. Hoboken, NJ: John Wiley and Sons; 2012.
19. Ohi R. Biliary atresia: a surgical perspective. Clin Liver Dis. 2000;4(4):779-804.
20. Haynes RC, Murad F. Adrenocorticotropic Hormone; Adrenocortical Steroids and Their Synthetic Analogs; Inhibitors of Adrenocortical Steroid Biosynthesis. 6th ed. New York, NY: MacMilan; 1980.
21. Miner PB Jr, Gaito JM. Bile flow in response to pharmacologic agents: hepatic DNA as a reference standard. Biochem Pharmacol. 1979;28(7):1063-1066.
22. Miner PB Jr, Sutherland E, Simon FR. Regulation of hepatic sodium plus potassium-activated adenossine triphosphatase activity by glucocorticoids in the rat. Gastroenterology. 1980;79(2):212-221.
23. Davenport M, De Ville de Goyet J, Stringer MD, et al. Seamless management of biliary atresia in England and Wales (1999-2002). Lancet. 2004;363(9418):1354-1357.
24. Hartley JL, Davenport M, Kelly DA. Biliary atresia. Lancet. 2009;374(9702):1704-1713.
25. Lampela H, Ritvanen A, Kosola S, et al. National centralization of biliary atresia care to an assigned multidisciplinary team provides high-quality outcomes. Scand J Gastroenterol. 2012;47(1):99-107.
26. Schreiber RA, Barker CC, Roberts EA, Martin SR; Canadian Pediatric Hepatology Research Group. Biliary atresia in Canada: the effect of centre caseload experience on outcome. J Pediatr Gastroenterol Nutr. 2010;51(1):61-65.
27. Serinet MO, Broué P, Jacquemin E, et al. Management of patients with biliary atresia in France: results of a decentralized policy 1986-2002. Hepatology. 2006;44(1):75-84.